Buy 1cP-LSD 10mcg Micro Pellets Online Europe
Buy 1cP-LSD 10mcg Micro Pellets is a high-grade, research-grade psychedelic compound provided by 3MMC Shop Eu, designed for controlled laboratory research. Each pellet is precisely formulated to ensure accuracy, consistency, and safety in experimental setups. Our 1cP-LSD is EU-certified, lab-tested, and manufactured under GMP standards in the Netherlands, guaranteeing top-quality research chemicals.
What is 1cP-LSD Micro Pellets?
1cP-LSD is a lysergamide derivative, structurally similar to LSD, used in neuropharmacological and psychological research. Our 10mcg micro pellets allow precise dosing, making them ideal for studies requiring low, controlled microdoses. Each pellet is carefully prepared to maintain chemical stability, purity, and reproducibility.
Why Choose 1cP-LSD Micro Pellets?
-
High Purity: Every batch is verified by certified EU laboratories with ≥99% purity.
-
Microdose Precision: 10mcg per pellet for exact experimental control.
-
Lab-Tested & EU-Certified: Manufactured in GMP-compliant European laboratories.
-
Safe Handling: Pellets reduce handling risks compared to powders.
Applications in Research
1cP-LSD Micro Pellets are suitable for:
-
Neuropharmacological studies on serotonin receptors
-
Psychopharmacology research requiring microdoses
-
Comparative studies with other lysergamides
-
Laboratory-based behavioral or analytical research
Important: 1cP-LSD Micro Pellets are strictly for laboratory research use only. They are not intended for human or veterinary consumption.
1cP-LSD is named for the cyclopropionyl group bound to the nitrogen of the polycyclic indole group of LSD. The cyclopropionyl group consists of a carbonyl ring with the chemical formula C3H6 bound to an amino group. The structure of 1cP-LSD contains a polycyclic group featuring a bicyclic hexahydro indole bound to a bicyclic quinoline group. At carbon 8 of the quinoline, an N,N-diethyl carboxamide is bound.
Pharmacological effects
1cP-LSD also likely interacts with a wide range of monoamine receptors, such as those for dopamine and norepinephrine. However, this is speculation based on observations of how LSD interacts with the brain as there is little to no data yet on the exact mechanisms specific to 1cP-LSD. It’s assumed the mechanisms are almost identical to 1P-LSD and LSD. This is due to the similarities in molecular structure and reported pharmacological effects.


